Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study

Med J Aust. 2023 Sep 4;219(5):218-226. doi: 10.5694/mja2.52039. Epub 2023 Jul 14.

Abstract

Objective: To investigate the demographic characteristics, substance use, and self-rated health of people entering treatment in New South Wales public health services for alcohol, amphetamine-type stimulants, cannabis, cocaine, or opioids use, by principal drug of concern.

Design: Baseline findings of a cohort study; analysis of data in patient electronic medical records and NSW minimum data set for drug and alcohol treatment services.

Setting, participants: People completing initial Australian Treatment Outcomes Profile (ATOP) assessments on entry to publicly funded alcohol and other drug treatment services in six NSW local health districts/networks, 1 July 2016 - 30 June 2019.

Main outcome measures: Socio-demographic characteristics, and substance use and self-rated health (psychological, physical, quality of life) during preceding 28 days, by principal drug of concern.

Results: Of 14 087 people included in our analysis, the principal drug of concern was alcohol for 6051 people (43%), opioids for 3158 (22%), amphetamine-type stimulants for 2534 (18%), cannabis for 2098 (15%), and cocaine for 246 (2%). Most people commencing treatment were male (9373, 66.5%), aged 20-39 years (7846, 50.4%), and were born in Australia (10 934, 86.7%). Polysubstance use was frequently reported, particularly by people for whom opioids or amphetamine-type stimulants were the principal drugs of concern. Large proportions used tobacco daily (53-82%, by principal drug of concern group) and reported poor psychological health (47-59%), poor physical health (32-44%), or poor quality of life (43-52%).

Conclusions: The prevalence of social disadvantage and poor health is high among people seeking assistance with alcohol, amphetamine-type stimulants, cannabis, cocaine, or opioids use problems. Given the differences in these characteristics by principal drug of concern, health services should collect comprehensive patient information during assessment to facilitate more holistic, tailored, and person-centred care.

Keywords: Addiction; Alcohol-related disorders; Amphetamine-related disorders; Drug misuse; Health services research; Marijuana abuse; Opioid-related disorders; eHealth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphetamine
  • Analgesics, Opioid / therapeutic use
  • Australia / epidemiology
  • Cannabis*
  • Central Nervous System Stimulants*
  • Cocaine*
  • Cohort Studies
  • Ethanol
  • Female
  • Humans
  • Male
  • New South Wales / epidemiology
  • Quality of Life
  • Substance-Related Disorders* / epidemiology
  • Substance-Related Disorders* / therapy

Substances

  • Analgesics, Opioid
  • Amphetamine
  • Central Nervous System Stimulants
  • Ethanol
  • Cocaine